3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Paclitaxel
5
liposomal doxorubicin
4
Topotecan
3
Doxorubicin
2
Carboplatin
2
Bevacizumab
2
saracatinib
1
pegfilgrastim
1
olaparib
1
cediranib
1
atezolizumab
1
Taxes
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Ifosfamide
1
Gemcitabine
1
Disulfides
1
Diathermy
1
Chemotherapy, Adjuvant
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Fallopian Tube Neoplasms
×
saracatinib
×
Clear all
NCT01196741
2015-05-05
SaPPrOC
University College, London
Phase 2/3
Completed
107 enrolled
17 charts